DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Essential Pharmaceuticals to commence sales of cell media products acquired from Lifeblood Medical

Essential Pharmaceuticals, LLC, a private company dedicated to providing specialty reagents and solutions to the life sciences market, announced today that the Company will commence sales and distribution of three distinct animal-component-free products: serum replacement, cryopreservation and clinical pathology media, formerly sold under the LiforCell® name.

28 Oct 2010

1000 Genomes Project publishes comprehensive map of genetic variations in Nature journal

Small genetic differences between individuals help explain why some people have a higher risk than others for developing illnesses such as diabetes or cancer. Today in the journal Nature, the 1000 Genomes Project, an international public-private consortium, published the most comprehensive map of these genetic differences, called variations, estimated to contain approximately 95 percent of the genetic variation of any person on Earth.

28 Oct 2010

New computational techniques to overcome obstacles in hard-to-study genes

Scientists have invented methods to scout the human genome's repetitive landscapes, where DNA sequences are highly identical and heavily duplicated. These advances, as reported today in Science, can identify subtle but important differences among people in the number and content of repeated DNA segments.

28 Oct 2010

deCODE genetics publishes high resolution recombination map of human genome in Nature journal

Scientists from deCODE genetics today publish in Nature the highest resolution recombination map of the human genome yet developed. Recombination is the reshuffling of the genome that occurs in the formation of eggs and sperm: we inherit one version of each chromosome from each of our parents, and create novel blends of the two that we pass on to our offspring.

28 Oct 2010

BioNanomatrix nanoAnalyzer 1000 System to be introduced at ASHG Annual Meeting

BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, will introduce next month the nanoAnalyzer 1000 System at the American Society of Human Genetics (ASHG) Annual Meeting from November 2-6, 2010 in Washington, D.C.

28 Oct 2010

Exact Sciences 2010 third quarter total revenue increases to $1.4 million from $1.3 million

Exact Sciences Corp. today announced its financial results for the third quarter ended September 30, 2010.

27 Oct 2010

Vical to present preclinical results of HSV-2 vaccine program at Keystone Symposium

Vical Incorporated today announced that the company's Vice President of Clinical Development, Richard T. Kenney, M.D., is presenting preclinical results from the company's herpes simplex type 2 (HSV-2) vaccine program in a poster session Friday morning at the Keystone Symposium on Immunological Mechanisms of Vaccination (Seattle, October 27 – November 1).

27 Oct 2010

Intellect obtains initial draft report of OXIGON Phase 1b clinical trial for Alzheimer’s disease

Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained an initial draft report of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON (OX1).

27 Oct 2010

Scientists develop new imaging technique that can detect breast cancer treatment response

Cancer Research UK scientists have developed a new imaging technique that can show when breast cancer treatment is working, weeks before current methods. The research is published in the British Journal of Cancer today1 (Wednesday).

27 Oct 2010

Scientists discover MSMB protein in urine can predict prostate cancer risk

British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer. The Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research found that the level of MSMB protein in urine could provide a fast and accurate prostate cancer diagnosis for doctors and patients, potentially replacing the currently painful and more costly approach a blood sample.

27 Oct 2010

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation.

27 Oct 2010

PCT technology improves DNA extraction method in forensic evidentiary samples

Pressure BioSciences, Inc. today announced that two scientific presentations at the 21st International Symposium on Human Identification have provided further evidence that pressure cycling technology offers an improved method for the extraction of DNA in the analysis of forensic evidentiary samples.

27 Oct 2010

Evotec, Apeiron Biologics enter collaboration

Evotec AG today announced that it has entered into a collaboration with Apeiron Biologics AG, to initially identify small molecule modulators of DREAM (Downstream Regulatory Element Antagonistic Modulator), a novel target involved in perception of various pain mechanisms. Further projects will be evaluated to potentially expand this cooperation in due course.

27 Oct 2010

Study: lncRNA are involved in host response to viral infection

Scientists have demonstrated for the first time that a certain class of RNA (known as long non-protein-coding RNA [lncRNA]) are involved in the host response to viral infection. These findings, published today in the online journal mBio-, could greatly change the way scientists look at the body's response to viral infection.

27 Oct 2010

Endocrine disrupting chemicals may affect human reproductive system: Research

New research has provided the first evidence that 'gender bending' chemicals which find their way from human products into rivers and oceans can have a significant impact on the ability of fish to breed in UK Rivers.

27 Oct 2010

Illumina announces single flow cell version of HiSeq 2000 sequencing system

Illumina, Inc. today announced HiSeq 1000, a single flow cell version of the company's HiSeq 2000 sequencing system. HiSeq 1000 is designed for researchers who want the ease of use, industry-leading cost per gigabase (Gb) and data rate of the HiSeq 2000 but do not currently require its throughput. As their research scales, users will be able to upgrade their system to the HiSeq 2000 and double their output.

From Illumina, Inc. 27 Oct 2010

Pacific Biosciences prices initial public offering of common stock

Pacific Biosciences of California, Inc. developer of single molecule, real-time (SMRT) technology for biological analysis, announced today the pricing of its initial public offering of 12,500,000 shares of its common stock at $16.00 per share. All shares are being sold by the company.

27 Oct 2010

Long non-protein coding RNAs respond to SARS virus infection, says study

For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal's cells during a respiratory virus attack may affect the outcome of the infection. Their findings are reported today in mBio, a journal of the American Society for Microbiology.

27 Oct 2010

Illumina 2010 third quarter revenue increases 50% to $237.3 million

Illumina, Inc. today announced its financial results for the third quarter of 2010.

From Illumina, Inc. 27 Oct 2010

MDI and Westburg enter exclusive distribution agreement for Detect-Ready MRSA panel in Benelux region

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Westburg BV today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in the Benelux region.

26 Oct 2010

DNA News and Research

Further Reading

Essential Pharmaceuticals to commence sales of cell media products acquired from Lifeblood Medical

1000 Genomes Project publishes comprehensive map of genetic variations in Nature journal

New computational techniques to overcome obstacles in hard-to-study genes

deCODE genetics publishes high resolution recombination map of human genome in Nature journal

BioNanomatrix nanoAnalyzer 1000 System to be introduced at ASHG Annual Meeting

Exact Sciences 2010 third quarter total revenue increases to $1.4 million from $1.3 million

Vical to present preclinical results of HSV-2 vaccine program at Keystone Symposium

Intellect obtains initial draft report of OXIGON Phase 1b clinical trial for Alzheimer’s disease

Scientists develop new imaging technique that can detect breast cancer treatment response

Scientists discover MSMB protein in urine can predict prostate cancer risk

Scripps Florida scientist receives grant from Landenberger Foundation for HIV research

PCT technology improves DNA extraction method in forensic evidentiary samples

Evotec, Apeiron Biologics enter collaboration

Study: lncRNA are involved in host response to viral infection

Endocrine disrupting chemicals may affect human reproductive system: Research

Illumina announces single flow cell version of HiSeq 2000 sequencing system

Pacific Biosciences prices initial public offering of common stock

Long non-protein coding RNAs respond to SARS virus infection, says study

Illumina 2010 third quarter revenue increases 50% to $237.3 million

MDI and Westburg enter exclusive distribution agreement for Detect-Ready MRSA panel in Benelux region

Understanding the DNA Damage Response in Innate Immunity eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo